ÇAVUŞOĞLU, Y. Et Al. 2013. Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study. 17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA) , (Florida, United States Of America).

ÇAVUŞOĞLU, Y., Korkmaz, S., DEMİRTAŞ, S., Gencer, E., Sasmaz, H., MUTLU, F., ... YILMAZ, M. B.(2013). Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study . 17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA), Florida, United States Of America

ÇAVUŞOĞLU, YÜKSEL Et Al. "Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study," 17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA), Florida, United States Of America, 2013

ÇAVUŞOĞLU, YÜKSEL Et Al. "Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study." 17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA) , Florida, United States Of America, 2013

ÇAVUŞOĞLU, Y. Et Al. (2013) . "Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study." 17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA) , Florida, United States Of America.

@conferencepaper{conferencepaper, author={YÜKSEL ÇAVUŞOĞLU Et Al. }, title={Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study}, congress name={17th Annual Scientific Meeting of the Heart-Failure-Society-of-America (HFSA)}, city={Florida}, country={United States Of America}, year={2013}}